HGG: Clinical Trials

1 trial for HGG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow HGG: new trials by email Literature Review of HGG trials Research Report on HGG

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Nivolumab, Nivolumab-IRDye800 - Brain Cancer, HGG
Early Phase 1RecruitingEben Rosenthal382026-03-272026-07-01

Narrower conditions

Brain Neoplasms (1)  ·  Glioma (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neuroectodermal Tumors (1)

Interventions

Nivolumab (1)

Sponsors

Eben Rosenthal (1)

Countries

United States (1)

Top investigators

Patrick Kelly, MD (1)